Clinical trial / 1986
Curcumin demonstrated a better anti-inflammatory response than placebo in patients with postoperative inflammation.
In a model evaluating postoperative inflammation, the anti-inflammatory activity of curcumin (diferuloyl methane) was examined in comparison with phenylbutazone and placebo. Both phenylbutazone and curcumin produced a better anti-inflammatory response than placebo.
- Study type
- Controlled clinical trial
- Who was studied
- Patients with postoperative inflammation (sample size not stated)
- What was measured
- Anti-inflammatory response
THE PAPER
Evaluation of anti-inflammatory property of curcumin (diferuloyl methane) in patients with postoperative inflammation.
Satoskar RR, Shah SJ, Shenoy SG. Int J Clin Pharmacol Ther Toxicol, 1986.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.